(1)
Non-Osteoporotic Loss of Spinal Bone. Denosumab As a Therapeutic Tool and Its Implications. Rev. Asoc. Arg. Ort. y Traumatol 2024, 89 (1), 83-89. https://doi.org/10.15417/issn.1852-7434.2024.89.1.1802.